Remove 2029 Remove Compounding Remove Drug Development
article thumbnail

Psychedelic drug market to reach $7.2 bn in 2029: GlobalData

Express Pharma

The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR). This ascent is propelled by favorable regulatory developments, including pioneering clinical trial guidelines from the FDA.

article thumbnail

Sustainability and technology advancement driving spectroscopy market

European Pharmaceutical Review

billion in 2029 at a compound annual growth rate (CAGR) of 7.9 Technological advancement in the process spectroscopy market As a key part of drug development and drug formulation, the report highlighted that demand for process spectroscopy is being fuelling by the growing pharmaceutical industry.